Cargando…

Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al

Detalles Bibliográficos
Autores principales: van Mulligen, Elise, Hazes, Johanna M W, Weel, Angelique E A M, de Jong, Pascal H P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307212/
https://www.ncbi.nlm.nih.gov/pubmed/31110029
http://dx.doi.org/10.1136/annrheumdis-2019-215641
_version_ 1783548768883310592
author van Mulligen, Elise
Hazes, Johanna M W
Weel, Angelique E A M
de Jong, Pascal H P
author_facet van Mulligen, Elise
Hazes, Johanna M W
Weel, Angelique E A M
de Jong, Pascal H P
author_sort van Mulligen, Elise
collection PubMed
description
format Online
Article
Text
id pubmed-7307212
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-73072122020-06-23 Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al van Mulligen, Elise Hazes, Johanna M W Weel, Angelique E A M de Jong, Pascal H P Ann Rheum Dis Correspondence Response BMJ Publishing Group 2020-07 2019-05-20 /pmc/articles/PMC7307212/ /pubmed/31110029 http://dx.doi.org/10.1136/annrheumdis-2019-215641 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Correspondence Response
van Mulligen, Elise
Hazes, Johanna M W
Weel, Angelique E A M
de Jong, Pascal H P
Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al
title Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al
title_full Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al
title_fullStr Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al
title_full_unstemmed Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al
title_short Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al
title_sort response to: ‘tara study: a new perspective on tapering drugs in ra’ by mishra et al
topic Correspondence Response
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307212/
https://www.ncbi.nlm.nih.gov/pubmed/31110029
http://dx.doi.org/10.1136/annrheumdis-2019-215641
work_keys_str_mv AT vanmulligenelise responsetotarastudyanewperspectiveontaperingdrugsinrabymishraetal
AT hazesjohannamw responsetotarastudyanewperspectiveontaperingdrugsinrabymishraetal
AT weelangeliqueeam responsetotarastudyanewperspectiveontaperingdrugsinrabymishraetal
AT dejongpascalhp responsetotarastudyanewperspectiveontaperingdrugsinrabymishraetal